Patents by Inventor Eric Stanton Diffenderfer

Eric Stanton Diffenderfer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sensitizing cells to proton radiation
    Patent number: 11779644
    Abstract: Materials and methods for enhancing the effectiveness of proton radiation therapy (e.g., high linear energy transfer (LET) proton radiation therapy) against tumor cells are provided herein.
    Type: Grant
    Filed: September 27, 2021
    Date of Patent: October 10, 2023
    Assignees: Humanetics Corporation, Trustees of the University of Pennsylvania
    Inventors: Adam J. Harvey, Michael D. Kaytor, Keith Cengel, Eric Stanton Diffenderfer
  • SENSITIZING CELLS TO PROTON RADIATION
    Publication number: 20220152201
    Abstract: Materials and methods for enhancing the effectiveness of proton radiation therapy (e.g., high linear energy transfer (LET) proton radiation therapy) against tumor cells are provided herein.
    Type: Application
    Filed: September 27, 2021
    Publication date: May 19, 2022
    Inventors: Adam J. Harvey, Michael D. Kaytor, Keith Cengel, Eric Stanton Diffenderfer
  • Sensitizing cells to proton radiation
    Patent number: 11129894
    Abstract: Materials and methods for enhancing the effectiveness of proton radiation therapy (e.g., high linear energy transfer (LET) proton radiation therapy) against tumor cells are provided herein.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: September 28, 2021
    Assignees: - Humanetics Corporation, The Trustees of the University of Pennsylvania
    Inventors: Adam J. Harvey, Michael D. Kaytor, Keith Cengel, Eric Stanton Diffenderfer
  • SENSITIZING CELLS TO PROTON RADIATION
    Publication number: 20190099491
    Abstract: Materials and methods for enhancing the effectiveness of proton radiation therapy (e.g., high linear energy transfer (LET) proton radiation therapy) against tumor cells are provided herein.
    Type: Application
    Filed: September 28, 2018
    Publication date: April 4, 2019
    Inventors: Adam J. Harvey, Michael D. Kaytor, Keith Cengel, Eric Stanton Diffenderfer